Astrup, 2009 - Google Patents
Blood clotting and related processesAstrup, 2009
- Document ID
- 3094372025314037148
- Author
- Astrup T
- Publication year
- Publication venue
- Adv Enzymol Relat Areas Mol Biol
External Links
Snippet
I. Introduction The need in these series for a review on the processes related to blood coagulation only a few years after Chargaff (52) published his paper is a sign of the rapid development of our knowledge in the field during recent years. Part of this work has been …
- 238000000034 method 0 title abstract description 61
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Astrup | Blood clotting and related processes | |
| US4158544A (en) | Process for preparing a biological composition for use as a reference control in diagnostic analysis | |
| Hovig | Release of a platelet-aggregating substance (adenosine diphosphate) from rabbit blood platelets induced by saline “extract” of tendons | |
| Howell | Theories of blood coagulation | |
| Seegers | Prothrombin | |
| Biggs et al. | The action of thromboplastic substances | |
| Stormorken | The preparation of proaccelerin deficient (parahemophilia) plasma for the assay of proaccelerin | |
| Hougie et al. | Stuart clotting defect. I. Segregation of an hereditary hemorrhagic state from the heterogeneous group heretofore called “stable factor”(SPCA, proconvertin, factor VII) deficiency | |
| CN103403519B (en) | It is prepared by serum | |
| Lechner | A new type of coagulation inhibitor | |
| US4027013A (en) | Clottable fibrinogen free factor VIII and albumin product and process | |
| McClaughry et al. | Prothrombin, thromboplastin, Ac-globulin and platelet accelerator: quantitative interrelationships | |
| FI64466B (en) | REQUEST OF REAGENTS FOR THE PROTECTION OF THE PROTOCOL | |
| Fahey et al. | Stability of prothrombin and Ac-globulin in stored human plasma as influenced by conditions of storage | |
| Jacox | Studies on the activation of a serum “prothrombin-converting factor” | |
| Johnson et al. | Platelets and their plasma cofactor activity in the activation of purified prothrombin | |
| Milstone | Purification of thrombin | |
| Glendening et al. | The site of inhibition of blood clotting by soy bean trypsin inhibitor | |
| Soulier et al. | Measurement of thromboplastic factors and profactors in plasma: I. Deficits in thromboplastin. Study of reagents. Measurements of antihemophilic and of platelet activities | |
| Fantl et al. | Comparison of blood clotting in marsupials and man. | |
| Nour-Eldin et al. | The separation of human and bovine plasma thromboplastin with ether and a study of its properties | |
| Dills et al. | Isolation of a copper bearing protein from cow's milk | |
| Straub et al. | Recurrent intravascular coagulation with renal cortical necrosis and recovery | |
| Grette | The release of 5-hydroxytryptamine (serotonin) from blood platelets during coagulation | |
| US2922745A (en) | Purification of profibrinolysin |